Add Yahoo as a preferred source to see more of our stories on Google. Pulmonologist doctor showing off virtual screen of lung medical issue. Healthcare medical technology concept. Approximately 25 ...

Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype Approval based on SWIFT trials showing ...

A monthly injection could enable severe asthma patients to stop taking daily steroid tablets without affecting their symptoms, a new trial has found. The drug, Tezepelumab (also known as Tezspir and ...

In December 2021, the US Food and Drug Administration (FDA) approved Tezspire (tezepelumab-ekko; Amgen, Inc and AstraZeneca AB), a thymic stromal lymphopoietin (TSLP) blocker, for the add-on ...

University of Utah Health is now offering a bronchial thermoplasty (BT) procedure, which can greatly reduce the frequency and severity of asthma attacks. Patients who experience severe asthma have ...

Please provide your email address to receive an email when new articles are posted on . Mucus scores included 6 for the nonbiologic group and 3 for the biologic group. Mucus scores also included 5 for ...

A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects. A landmark ...

Please provide your email address to receive an email when new articles are posted on . The SpiroNose can measure the volatome of exhaled breath. Clusters emerged at baseline based on TH2 features, ...

Bronchoscopy-based lower airway sequencing showed higher resistome abundance and diversity in COPD, bronchiectasis, and ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition. A better understanding of inflammation and lung immunity over the past two decades ...

PARIS — Pregnancy is a period of asthma instability; it entails an increased risk for exacerbations. While therapeutic de-escalation, if not the outright cessation of maintenance treatment, is common, ...

Approximately 25 million people in the U.S. have asthma, according to the Asthma and Allergy Foundation of America. While that number shows how common the condition has become, the severe form is more ...